Ajax-Loading

Takeda Pharmaceutical Co. Ltd. - Net Profit Margin

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in Percent.

The item "Net-Profit-Margin" stands at 0.7488 percent as of 09/30/2025, the lowest value at least since 06/30/2022, the period currently displayed.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Net Profit Margin" stands at 0.7488 Percent. This represents a decrease of -2.31 percentage points compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -5.63 percentage points compared to the value the year prior.
The 1 year change in percentage points is -5.63.
The 3 year change in percentage points is -4.94.

The Serie's long term average value is 4.84 percent. It's latest available value, on 09/30/2025, is 4.09 percentage points lower, compared to it's long term average value.
The Serie's change in percentage points from it's minimum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is +0.0.
The Serie's change in percentage points from it's maximum value, on 03/31/2023, to it's latest available value, on 09/30/2025, is -7.12.

Net Profit Margin for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Net Profit Margin905,699,262,464.00
LogoJohnson & Johnson - Net Profit Margin486,508,953,600.00
LogoAbbVie Inc - Net Profit Margin399,570,305,024.00
LogoRoche Holding AG - Net Profit Margin317,433,206,677.55
LogoAstraZeneca PLC - Net Profit Margin280,205,508,085.11